DAVIDE RONCARATI
Has grant
Permanent Assistant Professor in Molecular Biology
Research Interests
Explore related searches
Contact this professor
Recent Grants
Grant: Close
The essential transcriptional regulator HP1043 of Helicobacter pylori: a new target for the design of a new antibacterial drug
Open Date: 2018-03-01
Close Date: 2019-09-01
Articles (12)
Paradigm Shift in Gastric Cancer Prevention: Harnessing the Potential of Aristolochia olivieri Extract
Gastric cancer, particularly adenocarcinoma, is a significant global health concern. Environmental risk factors, such as Helicobacter pylori infection and diet, play a role in its development. This study aimed to characterize the chemical composition and evaluate the in vitro antibacterial and antitumor activities of an Aristolochia olivieri Colleg. ex Boiss. Leaves’ methanolic extract (AOME). Additionally, morphological changes in gastric cancer cell lines were analyzed. AOME was analyzed using HPLC-MS/MS, and its antibacterial activity against H. pylori was assessed using the broth microdilution method. MIC and MBC values were determined, and positive and negative controls were included in the evaluation. Anticancer effects were assessed through in vitro experiments using AGS, KATO-III, and SNU-1 cancer cell lines. The morphological changes were examined through SEM and TEM analyses. AOME contained several compounds, including caffeic acid, rutin, and hyperoside. The extract displayed significant antimicrobial effects against H. pylori, with consistent MIC and MBC values of 3.70 ± 0.09 mg/mL. AOME reduced cell viability in all gastric cancer cells in a dose- and time-dependent manner. Morphological analyses revealed significant ultrastructural changes in all tumor cell lines, suggesting the occurrence of cellular apoptosis. This study demonstrated that AOME possesses antimicrobial activity against H. pylori and potent antineoplastic properties in gastric cancer cell lines. AOME holds promise as a natural resource for innovative nutraceutical approaches in gastric cancer management. Further research and in vivo studies are warranted to validate its potential clinical applications.
Year:
2023
Collaborators (7)
Sara Salucci
University of Bologna
Barbara Zambelli
Associate Professor
University of Bologna
Michele Mari
Assistant Professor, Ricercatore a Tempo determinato RTD-B CHIM/08
Università degli Studi di Udine
MATTEO MICUCCI
Professore Associato
University of Urbino Carlo Bo
ALBERTO DANIELLI
Associate Professor in Molecular Biology
University of Bologna
Irene Faenza
University of Bologna
Vincenzo Scarlato
Professor of Molecular Biology
University of Bologna

How do I reach out?
Sign in for free to see their profile details and contact information.